References
- Agalou S, Karachalias N, Thornalley PJ, Tucker B, Dawnay AB (2002): Estimation of α-oxoaldehydes formed from the degradation of glycolytic intermediates and glucose fragmentation in blood plasma of human subjects with uraemia. Int Congr Ser 1245: 181–182.
- Aronson D, Rayfield EJ (2002): How hyperglycemia promotes atherosclerosis: Molecular mechanisms. Cardiovasc Diabetes 1: 1–10.
- Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornal Ley PJ (2003): Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 52: 2110–2120.
- Basta G, Schmidt AM, Acterina RD (2004): Advanced glycation end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63: 582–592.
- Chalas J, Claise C, Edeas M, Messaoudi C, Vergnes L, Abella A, Lindenbaum A (2001): Effect of ethyl esterification of phenolic acids on low-density lipoprotein oxidation. Biomed Pharmacother 55: 54–60.
- Chang WS (1982): Studies on active principles of hypoglycemic effect from Psidium guajava (I). Master Thesis. The Graduate Institute of Pharmacy, Taipei Medical College.
- Chen KC, Hsieh CL, Peng CC, Hsieh-Li HM, Chiang HS, Huang KD, Peng RY. (2007): Brain derived metastatic prostate cancer DU-145 cells are effectively inhibited in vitro by guava (Psidium guajava L.) leaf extracts. Nutr Cancer 58: 93–106.
- Chen KS, Cheng JT (1985): Active fraction of Psidium guajava Linn for hypoglycemic action. J Taiwan Pharm Assoc 37: 29–35.
- Duffy CF, Power RF (2001): Antioxidant and antimicrobial properties of some Chinese plant extracts. Int J Antimicrob Agents 17: 527–529.
- Harper HA, Rodwell VW, Mayes PA (1977): Review of Physiological Chemistry, 16th ed. Los Altos, Lange Medical Publications, pp. 584–585.
- Hollman PCH, Katan MB (1999): Dietary flavonoids: Intake, health effects and bioavailability. Food Chem Toxicol 37: 937–942.
- Hsieh CL, Lin YC, Ko WS, Peng CH, Huang CN, Peng RY (2005): Inhibitory effect of some selected nutraceutic herbs on LDL glycation induced by glucose and glyoxal. J Ethnopharmacol 102: 357–363.
- Hsieh CL, Huang CN, Lin YC, Peng RY (2007): Molecular action mechanism against apoptosis by aqueous extract from guava budding leaves elucidated with human umbilical vein endothelial cell (HUVEC) model. J Agric Food Chem 55: 8523–8533.
- Ichiki H, Miura T, Kubo M, Ishihara E, Komatsu Y, Tanigawa K, Okada M (1998): New antidiabetic compounds, mangiferin and its glucoside. Biol Pharm Bull 21: 389–390.
- Iwu MM (1993): Handbook of African Medicinal Plants. Boca Raton, CRC Press, pp. 223–224.
- Kerry NL, Abbey M (1997): Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis 135: 93–102.
- Kikuchi S, Shinpo K, Takeuchi M, Yamagishi S, Makita Z, Sasaki N, Tashiro K (2003): Glycation – a sweet tempter for neuronal death. Brain Res Rev 41: 306–323.
- Lee D, Park EJ, Cuendet M, Axelrod F, Chvez PI, Fong HHS, Pezzuto JM, Kinghorn AD (2001): Cyclooxygenase-inhibitory and antioxidant constituents of aerial parts of Antirhea acutata. Bioorg Med Chem 11: 1565–1568.
- Lee SH (1986): Studies on active principles of hypoglycemic effect from Psidium guajava (I). Master Thesis. The Graduate Institute of Pharmacy, Taipei Medical College.
- Margolis RN, Evans RM, O’Malley BW, Consortium NA (2005): The nuclear receptor signaling atlas: development of a functional atlas of nuclear receptors. Mol Endocrinol 19: 2433–2436.
- Mosinger BJ (1995): Copper-induced and photosensitive oxidation of low-density lipoprotein. The relation to cholesterol level and inter-species differences. Biochim Biophys Acta 1270: 73–80.
- Mullarkey CJ, Edelstein D, Brownlee M (1990): Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173: 932–939.
- Munch G, Gerlach M, Sian J, Wong A, Piederer P (1998): Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress? Ann Neurol 44(Suppl. 1): S85–S88.
- Pacini G, Bergman RN (1986): MINMOD: A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Meth Prog Biomed 23: 113–122.
- SAS (1985): SAS User’s Guide: Statistics. Cary, NC, SAS Institute, Inc., p. 127.
- Peng RY, Hsieh CL, Chen KC (2007): Review on the medicinal uses of Psidium guajava. In: Singh VK, Govil JN, eds., Phytopharmacology & Therapeutic Values II, Recent Progress in Medicinal Plants (RPMP). Houston, Stadium Press, pp. 215–248.
- Stentz FB, Kitabchi AE (2005): Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species. Biochem Biophys Res Commun 335: 491–495.
- Stern DM, Yan SD, Yan SF, Schmidt AM (2002): Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res Rev 1: 1–15.
- Uchida K (2000): Role of reactive aldehyde in cardiovascular diseases. Free Radical Biol Med 28: 1685–1696.
- Wautier JL, Wautier MP, Schmidt AM, Anderson GM, Hori O, Zoukourian C, Capron L, Chappey O, Yan SD, Brett J (1994): Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 91: 7742–7746.
- Wondrak GT, Cervantes-Laurean D, Roberts MJ (2002): Identification of alpha-dicarbonyl scavengers for cellular protection against carbonyl stress. Biochem Pharmacol 63: 361–373.
- Yagi K (1989): A simple fluorometric assay for lipid peroxides in blood serum or plasma. In: Quintanilha A and Weber H, CRC Handbook of Free Radicals and Antioxidants in Biomedicine Vol. III. Boca Raton, CRC Press, p. 215.
- Yamanaka N, Oda O, Nagao S (1997): Prooxidant activity of caffeic acid, dietary non-flavonoid phenolic acid, on Cu2+-induced low density lipoprotein oxidation. FEBS Lett 405: 186–190.